iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Shares Acquired by Envestnet Asset Management Inc.

Envestnet Asset Management Inc. lifted its holdings in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE – Get Rating) by 3.1% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 6,293 shares of the company’s stock after buying an additional 191 shares during the period. Envestnet Asset Management Inc. owned approximately 0.28% of iShares U.S. Pharmaceuticals ETF worth $1,171,000 at the end of the most recent quarter.

Several other hedge funds have also made changes to their positions in IHE. International Assets Investment Management LLC acquired a new stake in iShares U.S. Pharmaceuticals ETF in the fourth quarter valued at about $25,000. First Manhattan Co. acquired a new stake in shares of iShares U.S. Pharmaceuticals ETF during the 1st quarter valued at approximately $46,000. Blair William & Co. IL acquired a new stake in shares of iShares U.S. Pharmaceuticals ETF during the 1st quarter valued at approximately $58,000. Y.D. More Investments Ltd purchased a new position in shares of iShares U.S. Pharmaceuticals ETF during the 4th quarter worth approximately $75,000. Finally, Concorde Asset Management LLC purchased a new position in shares of iShares U.S. Pharmaceuticals ETF during the 4th quarter worth approximately $202,000.

iShares U.S. Pharmaceuticals ETF Price Performance

Shares of IHE opened at $174.69 on Thursday. The firm has a 50 day simple moving average of $178.34 and a 200-day simple moving average of $181.63. iShares U.S. Pharmaceuticals ETF has a 1-year low of $166.99 and a 1-year high of $197.28. The stock has a market cap of $375.58 million, a price-to-earnings ratio of 16.27 and a beta of 0.70.

iShares U.S. Pharmaceuticals ETF Company Profile

(Get Rating)

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.